GTX compared with INDV: revenue, margins and what each company keeps, and the suppliers and customers both name

GTXGarrett Motion Inc.

Mkt capRevenueRevenue

INDVIndivior Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

GTXGarrett Motion Inc.

INDVIndivior Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

GTX

1 of 3at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±11.3%▲+0.67%×0.06

Q2 FY26—▼−3.81%—

Q1 FY26±10.3%▲+24.99%×2.43

Feb 19 '26±7.0%▼−6.39%×0.91

INDV

0 of 3at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±12.3%▲+1.38%×0.11

Q2 FY26—▼−6.60%—

= impliedGTX realized, solidINDV realized, hatchedOne scale, both sides: full bar = 25%× = |realized| ÷ impliedSource: market data

Q1 FY26

±12.8%

▲+7.70%

×0.60

Feb 26 '26±13.8%▲+0.24%×0.01

GTXGarrett Motion Inc.

20.90▼−7.03%· post 20.80

Mkt cap$3.9BRevenue$930MQ3 FY26Revenue$3.6BFY25

INDVIndivior Pharmaceuticals, Inc.

35.34▲+0.25%· post 35.35

ClosedOct 30 '26

Mkt cap$4.2BRevenue$356MQ3 FY26Revenue$1.2BFY25

Compare

ClosedOct 30 '26

GTXGarrett Motion Inc.

INDVIndivior Pharmaceuticals, Inc.

20.90▼−7.03%post 20.80

Price

35.34▲+0.25%post 35.35

$3.9B

Mkt cap

$4.2B

Q3 FY26$930M

Revenue

$356MQ3 FY26

FY25$3.6B

Revenue

$1.2BFY25

GTX20.90▼−7.03%vsINDV35.34▲+0.25%ClosedOct 30 '26